VerifiedBiotechnology Research· Founded 2018

Icosavax, Inc

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle. Icosavax is a member of the AstraZeneca Group.

7-day free trial · no credit card

HeadquartersSeattle, United StatesEmployees56(11 to 50)Annual revenue<$1MFounded year2018Websiteicosavax.comLinkedIn profileLinkedIn

Verified contacts

20

available on Kipplo

LinkedIn employees

56

11 to 50 range

Open roles

no listings

Distinct roles

20

indexed titles

Tech stack

4

tools in use

Monthly traffic

180

organic / mo

Sign up free to see all 20 verified contacts at Icosavax, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

20 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Icosavax, Inc

20 distinct titles indexed · top 10 shown.

  • 1associate scientist
  • 1cso
  • 1director - cmc, analytical and formulation development
  • 1director of drug substance operations
  • 1director of quality control
  • 1director, accounting
  • 1director, global program management
  • 1director, translational cmc
  • 1quality assurance manager
  • 1research associate
  • +10more titles

Sign up to unlock all 20 contacts at Icosavax, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 20 verified contacts at Icosavax, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Icosavax, Inc | Kipplo Discover